DNA-sequencing giant Illumina has formed a new company, called Grail, to develop liquid biopsies capable of spotting cancer before symptoms arise. The start-up is working on a low-cost "pan-cancer" test that can detect multiple cancer types early, which it hopes to introduce by 2019.
from Cancer via ola Kala on Inoreader http://ift.tt/1qiym33
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου